We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $1.01B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
-12.1%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$574M
AUM Growth
-$81.1M
Cap. Flow
+$5.94M
Cap. Flow %
1.03%
Top 10 Hldgs %
31.9%
Holding
117
New
4
Increased
57
Reduced
36
Closed
8

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$8.75M
2
WBD icon
Warner Bros
WBD
+$1.12M
3
AAPL icon
Apple
AAPL
+$893K
4
DD icon
DuPont de Nemours
DD
+$583K
5
DIS icon
Walt Disney
DIS
+$530K

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$7.92M
2
T icon
AT&T
T
+$1.55M
3
DE icon
Deere & Co
DE
+$446K
4
ELV icon
Elevance Health
ELV
+$422K
5
WBA
Walgreens Boots Alliance
WBA
+$251K

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Healthcare 16.61%
3 Industrials 14.55%
4 Financials 11.39%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
51
Procter & Gamble
PG
$343B
$1.29M 0.23%
8,995
+59
+0.7% +$8.87K
LLY icon
52
Eli Lilly
LLY
$1.07T
$1.22M 0.21%
3,769
+603
+19% +$181K
AMZN icon
53
Amazon
AMZN
$2.5T
$1.16M 0.2%
10,946
+506
+5% +$63.3K
VTI icon
54
Vanguard Total Stock Market ETF
VTI
$654B
$1.16M 0.2%
6,123
PFE icon
55
Pfizer
PFE
$140B
$1.14M 0.2%
21,758
+4,342
+25% +$221K
GOOGL icon
56
Alphabet (Google) Class A
GOOGL
$3.91T
$1.08M 0.19%
9,880
+1,580
+19% +$186K
BRK.B icon
57
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.06M 0.18%
3,873
+289
+8% +$90.7K
SPY icon
58
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.03M 0.18%
2,720
+238
+10% +$97.5K
VZ icon
59
Verizon
VZ
$194B
$1M 0.17%
19,765
-1,940
-9% -$98.1K
GOOG icon
60
Alphabet (Google) Class C
GOOG
$3.9T
$857K 0.15%
7,840
+3,180
+68% +$376K
WBD icon
61
Warner Bros
WBD
$64.6B
$813K 0.14%
+60,608
New +$1.12M
PLTR icon
62
Palantir
PLTR
$295B
$802K 0.14%
88,385
-145
-0.2% -$1.43K
VYM icon
63
Vanguard High Dividend Yield ETF
VYM
$81.1B
$772K 0.13%
7,588
-300
-4% -$32.5K
CSCO icon
64
Cisco
CSCO
$450B
$745K 0.13%
17,468
-8
-0% -$383
COST icon
65
Costco
COST
$415B
$712K 0.12%
1,486
-63
-4% -$32K
EVLV icon
66
Evolv Technologies
EVLV
$943M
$681K 0.12%
256,008
BCPC
67
Balchem Corp
BCPC
$5.23B
$651K 0.11%
5,020
-253
-5% -$31.7K
TSLA icon
68
Tesla
TSLA
$1.24T
$643K 0.11%
2,865
+3
+0.1% +$819
INTC icon
69
Intel
INTC
$466B
$623K 0.11%
16,659
+4,384
+36% +$190K
CSX icon
70
CSX Corp
CSX
$98.6B
$553K 0.1%
19,036
-1,499
-7% -$48.9K
LMT icon
71
Lockheed Martin
LMT
$134B
$550K 0.1%
1,279
+13
+1% +$5.71K
DUK icon
72
Duke Energy
DUK
$102B
$547K 0.1%
5,099
+304
+6% +$33.4K
UNH icon
73
UnitedHealth
UNH
$382B
$533K 0.09%
1,037
+145
+16% +$72.8K
FTV icon
74
Fortive
FTV
$19B
$517K 0.09%
12,614
+1
+0% +$44
PEP icon
75
PepsiCo
PEP
$186B
$504K 0.09%
3,023
+401
+15% +$67.5K

Similar funds

Steigerwald Gordon & Koch's Q2 2022 Portfolio in Review

As of Q2 2022, Steigerwald Gordon & Koch held 117 positions worth $574M, down 12% from $655M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Steigerwald Gordon & Koch's Q2 2022 filing shows 4 new, 57 increased, 36 reduced and 8 closed positions. Its largest new stake was Zoetis: 50,579 shares worth $8.69M. The largest sale was Bausch Health, an estimated $7.92M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Steigerwald Gordon & Koch's largest Q2 2022 buy was Zoetis: 50,579 shares worth $8.69M.
  • Steigerwald Gordon & Koch added most to Apple in Q2 2022, an estimated $893K increase.
  • Steigerwald Gordon & Koch's biggest Q2 2022 reduction was AT&T, cutting an estimated $1.55M.
  • Steigerwald Gordon & Koch fully exited Bausch Health in Q2 2022, selling an estimated $7.92M.
  • Steigerwald Gordon & Koch's ten largest holdings make up 32% of its $574M portfolio in Q2 2022.
  • Steigerwald Gordon & Koch opened 4 new positions and closed 8 in Q2 2022.
  • Steigerwald Gordon & Koch's portfolio value fell 12% quarter-over-quarter to $574M.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2022, filed 14 Jul 2022.